VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -21.9% | 11,684 | +20.2% | 0.00% | – |
| Q2 2023 | $64 | +255.6% | 9,718 | +263.0% | 0.00% | – |
| Q1 2023 | $18 | -33.3% | 2,677 | -27.1% | 0.00% | – |
| Q4 2022 | $27 | -99.9% | 3,672 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | -10.0% | 3,672 | 0.0% | 0.00% | – |
| Q2 2022 | $40,000 | -2.4% | 3,672 | 0.0% | 0.00% | – |
| Q1 2022 | $41,000 | -29.3% | 3,672 | -0.8% | 0.00% | – |
| Q4 2021 | $58,000 | +5.5% | 3,700 | +14.9% | 0.00% | – |
| Q3 2021 | $55,000 | -27.6% | 3,219 | -9.2% | 0.00% | – |
| Q2 2021 | $76,000 | +43.4% | 3,547 | 0.0% | 0.00% | – |
| Q1 2021 | $53,000 | +60.6% | 3,547 | +37.3% | 0.00% | – |
| Q4 2020 | $33,000 | +371.4% | 2,584 | +231.7% | 0.00% | – |
| Q3 2020 | $7,000 | -82.9% | 779 | -78.4% | 0.00% | – |
| Q2 2020 | $41,000 | -40.6% | 3,601 | -46.0% | 0.00% | – |
| Q1 2020 | $69,000 | +40.8% | 6,663 | +122.1% | 0.00% | – |
| Q4 2019 | $49,000 | +188.2% | 3,000 | +131.5% | 0.00% | – |
| Q3 2019 | $17,000 | – | 1,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |